Search

Author/Creator Østergaard, M

71. THU0088 Structural damage progression in patients treated with methotrexate, baricitinib monotherapy or baricitinib + methotrexate based on their level of clinical response in the phase 3 ra-begin study. (15th June 2017)

Authors:
Heijde, D van der; Durez, P; Schett, G; Naredo, E; Østergaard, M; Meszaros, G; Bello, N; Torre, I De la; Lopez-Romero, P; Schlichting, D; Nantz, E; Fleischmann, R
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

72. THU0104 Both MRI and HAQ-DI can predict relapses following all treatment withdrawal in MTX-NAÏVE patients with RA in remission after 12 months of abatacept therapy in the avert trial. (15th June 2017)

Authors:
Ahmad, H; Baker, J; Østergaard, M; Emery, P; Huizinga, T; Ye, J; Banerjee, S; Conaghan, P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

73. THU0175 Inflammation detected with modern sensitive mri analysis demonstrates that therapeutic response as early as one month predicts 12-month radiographic progression: data from a study using tofacitinib and methotrexate in methotrexate-naÏve patients with early ra. (15th June 2017)

Authors:
Conaghan, PG; Bowes, MA; Østergaard, M; Guillard, G; Chapman, D; Stein, A; Andrews, J; Xie, Z; Koenig, A; Soma, K; Wilkinson, B
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

74. THU0366 Efficacy of Adalimumab in Patients with Axial Spondyloarthritis: Results of an Investigator-Initiated 12-Weeks Randomized Double-Blind Placebo Controlled Trial with a 12 Weeks Open-Label Extension Phase. (23rd January 2014)

Authors:
Pedersen, S. J.; Sørensen, IJ; Loft, AG; Hindrup, JS; Thamsborg, G; Asmussen, K; Kluger, E; Nørregaard, J; Christensen, TG; Jurik, AG; Møller, JM; Hasselquist, M; Skjødt, T; Mikkelsen, D; Østergaard, M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A289
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

75. THU0393 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through 3 years: long-term results of two randomised double-blind placebo-controlled phase 3 studies. (15th June 2017)

Authors:
Kvien, TK; Deodhar, A; Gossec, L; Conaghan, PG; Strand, V; Østergaard, M; Williams, N; Porter, B; Gandhi, K; Jugl, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
355
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

77. Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression. (March 2014)

Authors:
Ellingsen, T; Hansen, I; Thorsen, J; Møller, BK; Tarp, U; Lottenburger, T; Andersen, LS; Skjødt, H; Pedersen, JK; Lauridsen, UB; Svendsen, A; Lindegaard, H; Jacobsen, S; Østergaard, M; Vestergaard, A; Jurik, AG; Junker, P; Christensen, AF; Hetland, ML; Hørslev-Petersen, K
Journal:
Scandinavian journal of rheumatology
Issue:
Volume 43:Number 2(2014)
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗